Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -128,000 | -353,000 | -247,000 | -112,000 | -112,000 |
| Depreciation Amortization | -1,000 | -3,000 | -3,000 | -2,000 | -1,000 |
| Accounts receivable | 8,000 | 9,000 | 9,000 | 5,000 | 5,000 |
| Accounts payable and accrued liabilities | -3,000 | 24,000 | 24,000 | 11,000 | 3,000 |
| Other Working Capital | -31,000 | -194,000 | -164,000 | -185,000 | -37,000 |
| Other Operating Activity | 17,000 | 35,000 | 19,000 | 18,000 | 10,000 |
| Operating Cash Flow | $-138,000 | $-482,000 | $-362,000 | $-265,000 | $-132,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 107,000 | -3,000 | 179,000 | 101,000 | 7,000 |
| PPE Investments | N/A | -2,000 | -1,000 | -1,000 | -1,000 |
| Sale Of Investment | 7,000 | 71,000 | 70,000 | 69,000 | 26,000 |
| Investing Cash Flow | $114,000 | $66,000 | $248,000 | $169,000 | $32,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,000 | 439,000 | 153,000 | 145,000 | 142,000 |
| Other Financing Activity | 0 | 49,000 | 49,000 | 49,000 | 0 |
| Financing Cash Flow | $3,000 | $488,000 | $202,000 | $194,000 | $142,000 |
| Beginning Cash Position | 225,000 | 153,000 | 153,000 | 153,000 | 153,000 |
| End Cash Position | 204,000 | 225,000 | 241,000 | 251,000 | 195,000 |
| Net Cash Flow | $-21,000 | $72,000 | $88,000 | $98,000 | $42,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,000 | -482,000 | -362,000 | -265,000 | -132,000 |
| Capital Expenditure | N/A | -2,000 | -1,000 | -1,000 | -1,000 |
| Free Cash Flow | -138,000 | -484,000 | -363,000 | -266,000 | -133,000 |